Nanotherapeutic Solutions for Cardiovascular Disease

Methodist Debakey Cardiovasc J. 2016 Sep;12(3):132-133. doi: 10.14797/mdcj-12-3-132.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Agents / administration & dosage*
  • Cardiovascular Diseases / drug therapy*
  • Drug Delivery Systems*
  • Humans
  • Nanomedicine / trends*
  • Nanoparticles*

Substances

  • Cardiovascular Agents